According to the report “Transcatheter Aortic Valve Replacement (TAVR) Market”, published by Market Data Forecast, the global market is projected to reach USD 4.29 billion by 2021, at a CAGR of 18.50% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/
Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high risk patients. Transcatheter heart valve replacement systems are referred as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/request-sample
Growing adoption of minimally invasive therapies, increasing number of severe aortic stenosis disorder patients, rising number of clinical trials cardiovascular indications, and growing number of product launches in this market are driving the growth of global transcatheter aortic valve replacement (TAVR) market. In addition, rising technological advancements, increasing demand for minimally invasive catheter-based procedures as compared to conventional open heart therapies, and growing number of patients choosing an efficient & effective therapy with quick recovery are further propelling the growth of global transcatheter aortic valve replacement (TAVR) market.
Global Market for Transcatheter Aortic Valve Replacement (TAVR) is segmented as:
1.On the basis of surgery method
2.On the basis of valve frame material
3.On the basis of valve size
•14mm to 18mm
•18mm to 22mm
•22mm to 29mm
4.On the basis of valve leaflets material
•Bovine Heart Tissue
•Cow Heart Tissue
•Other Valve Leaflets Material
5.On the basis of end users
•Ambulatory Surgical Centres
•Cardiac Catheterization Laboratories
6.On the basis of Geography
•Middle East & Africa
The key players in global transcatheter aortic valve replacement (TAVR) market such as, Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL FREE)